Monte Rosa Therapeutics (GLUE) Return on Invested Capital (2023 - 2026)

Monte Rosa Therapeutics' Return on Invested Capital history runs 4 years deep, the most recent figure standing at 0.0% for Q1 2026.

• In Q1 2026, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital was 0.0% for Q1 2026 at Monte Rosa Therapeutics, down from 0.0% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q2 2025 to a low of 0.01% in Q1 2024.
• Historically, Return on Invested Capital has averaged 0.0% across 4 years, with a median of 0.0% in 2023.
• The sharpest annual moves came in 2024 and 2025: Return on Invested Capital changed 0 bps in 2024, then gained 1 bps in 2025.
• A 4-year view of Return on Invested Capital shows it stood at 0.01% in 2023, then soared by 50 bps to 0.0% in 2024, then soared by 92 bps to 0.0% in 2025, then plunged by 707 bps to 0.0% in 2026.
• The last three Return on Invested Capital figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.